Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.
Press releases published on September 9, 2025
U.S. Oral Surgery Management Supports OMS Foundation
GlobeNewswire
·
September 9, 2025
IRVING, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) is proud to announce its continued support of the OMS Foundation, a 501(c) (3) nonprofit that strives to improve the quality and safety of patient care by fueling …
Capricor Therapeutics Responds to FDA Posting of Complete Response Letter (CRL) for Deramiocel
GlobeNewswire
·
September 9, 2025
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today issued a statement regarding the U.S. Food and Drug …
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
GlobeNewswire
·
September 9, 2025
SARASOTA, FL, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that the Japan Patent Office has granted …
Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 9, 2025
HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025, at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm …
Mark Mikhael Appointed to Make America Healthy Again PAC Board to Advance Positive Dialogue on Compounding and Patient-Centered Care
GlobeNewswire
·
September 9, 2025
ORLANDO, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation’s leading compound pharmacies, announced today that their CEO, Mark Mikhael, PharmD, has been appointed to the board of Make America Healthy Again (MAHA …
Confluent Health Launches First-of-its-Kind Student Loan Repayment Program to Attract Next Generation of Physical, Occupational and Speech Therapy Professionals
GlobeNewswire
·
September 9, 2025
LOUISVILLE, Ky., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a national leader in musculoskeletal (MSK) care, today announced the launch of a groundbreaking student loan repayment initiative designed to attract top physical therapy (PT), …
All Heart Homecare Expands Services with Specialized Holocaust Program
GlobeNewswire
·
September 9, 2025
BROOKLYN, N.Y., Sept. 09, 2025 (GLOBE NEWSWIRE) -- All Heart Homecare — Brooklyn’s premier home care agency and a trusted partner for families across New York City for over 13 years — is proud to expand its wide range of services by introducing the …
Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program
GlobeNewswire
·
September 9, 2025
BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tive, the global leader in real-time supply chain visibility solutions, has recently partnered with AstraZeneca to bring Tive Tag temperature visibility functionality to FluMist® Home, AstraZeneca’s at-home flu …
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress
GlobeNewswire
·
September 9, 2025
Presentation to highlight findings from the first phase of the Company’s ongoing first-in-human proof-of-concept (PoC) clinical trial THE WOODLANDS, TX, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company …
Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
GlobeNewswire
·
September 9, 2025
Awarded grant supports dedicated pediatric continuous renal replacement therapy (CRRT) device in development for patients between 2.5 and 20 kg where therapeutic options are scarce Company working to advance Vivian™ towards an investigational device study …
Aviv Clinics Showcases New Study on Hyperbaric Oxygen Therapy’s Effectiveness in Improving Post-Concussion Symptoms from Childhood Traumatic Brain Injury
GlobeNewswire
·
September 9, 2025
ORLANDO, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- An estimated 2.3 million children in the U.S. are impacted by concussions annually. Yet, while the immediate effects of a concussion may subside, research shows that many individuals continue to experience …
Parexel Establishes New Global Headquarters in Raleigh’s North Hills Innovation District
GlobeNewswire
·
September 9, 2025
RALEIGH, N.C., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the opening of its new …
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
GlobeNewswire
·
September 9, 2025
European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US 13 subjects recruited (treated, enrolled, or screened) Forecasts total recruitment of 20 or more subjects by end of September On track to recruit to 45 …
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
GlobeNewswire
·
September 9, 2025
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New therapeutic options for people living with MSA, a rare …
Aphaia Pharma Initiates Second Phase 2 Trial of Oral Candidate in Obesity
GlobeNewswire
·
September 9, 2025
Second Phase 2 trial builds on encouraging initial results from a prior Phase 2 study Aphaia’s formulation activates gastrointestinal nutrient-sensing signaling pathways to modify the course of obesity and associated metabolic diseases ZUG, Switzerland, …
Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
GlobeNewswire
·
September 9, 2025
SAN FRANCISCO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI‑powered physician‑ …
SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit
GlobeNewswire
·
September 9, 2025
FORT LAUDERDALE, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and …
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
GlobeNewswire
·
September 9, 2025
Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward …
Hairy Cell Leukemia Foundation Celebrates 40th Anniversary
GlobeNewswire
·
September 9, 2025
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Hairy Cell Leukemia Foundation (HCLF), the only nonprofit organization in the United States dedicated to Hairy Cell Leukemia (HCL), is celebrating 40 years of progress in supporting the development and …
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
GlobeNewswire
·
September 9, 2025
BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …